Abstract:Graphical and Lay Summary Two parameters are particularly critical when developing manufacturing cell lines: short timelines and high productivity. This study demonstrates the possibility to concomitantly reduce the timelines by using low viability pools and increase the productivity of the clones by using cold capture, an immunostaining protocol used for two decades. Using Beacon, we validated the positive impact of cold capture on titers and specific productivities. Furthermore, we showed that combining an early sorting with cold capture protocol systematically increased Qp of cells in batch assays. The method developed in this study provides valuable improvement for cell line development workflows. Improving current cell line development workflows can either focus on increasing the specific productivity of the cell lines or shortening timelines to reach the clinic as fast as possible. In this work, using the Beacon platform, we have combined two distinct protocols – early cloning with low‐viability pools, and IgG membrane staining‐, to concomitantly reach both objectives, and generate highly productive CHO clones in shorter timelines. Fast‐sorting approaches using low‐viability pools in combination with the Beacon platform have recently been reported to shorten CLD timelines. However, the low recovery led to a drastic reduction in the clone number obtained postcloning. Here, we report a combined approach of fast‐sorting and fluorescent membrane staining. With this new protocol, the cells reach a correct recovery, allowing to fully exploit the Beacon screening capacities. In addition, by using a fluorescent staining recognizing the secreted IgG, we were able to enrich the fraction of highly secreting cells prior to cloning and we obtained significant increases in the cell's specific productivity. The combination of these two protocols has a synergistic effect, and as they help discarding the dead and nonproducing populations prior to cloning, they increase the throughput power of the Beacon platform and the detection of super productive clones.

Methods for Estimating the Probability of Clonality in Cell Line Development

Measuring the aggregation of CHO cells prior to single cell cloning allows a more accurate determination of the probability of clonality

Genome‐wide analysis of single nucleotide variants allows for robust and accurate assessment of clonal derivation in cell lines used to produce biologics

Assuring Clonality on the Beacon Digital Cell Line Development Platform

Coupling picodroplet microfluidics with plate imaging for the rapid creation of biomanufacturing suitable cell lines with high probability and improved multi-step assurance of monoclonality

When will we have a clone? An industry perspective on the typical CLD timeline

High‐throughput and automation advances for accelerating single‐cell cloning, monoclonality and early phase clone screening steps in mammalian cell line development for biologics production

Genomic barcoding for clonal diversity monitoring and control in cell-based complex antibody production

Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning

Assurance of monoclonality in one round of cloning through cell sorting for single cell deposition coupled with high resolution cell imaging

Microfluidic chip‐based single‐cell cloning to accelerate biologic production timelines

A single-step FACS sorting strategy in conjunction with fluorescent vital dye imaging efficiently assures clonality of biopharmaceutical production cell lines.

Combined approach of selective and accelerated cloning for microfluidic chip‐based system increases clone specific productivity

Selection of High-Producing Clones by a Relative Titer Predictive Model Using Image Analysis.

Simplifying stable CHO cell line generation with high probability of monoclonality by using microfluidic dispensing as an alternative to fluorescence activated cell sorting

Genetic Analysis of the Clonal Stability of Chinese Hamster Ovary Cells for Recombinant Protein Production.

Investigating Subpopulation Dynamics in Clonal CHO-K1 Cells with Single-Cell RNA Sequencing

Unlocking Potential: A Comprehensive Overview of Cell Culture Banks and Their Impact on Biomedical Research

Estimating Clonality

Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production

Genetic Analysis of Heterogeneous Sub-Clones in Recombinant Chinese Hamster Ovary Cells.